< 1 minute read
Dec. 20, 2021
BIIB091: a Reversible BTK Inhibitor
BIIB091
oral reversible BTK kinase inhibitor Ph. I candidate for multiple sclerosis from prior BTK inhibitor BIIB0685 Journal of Medicinal Chemistry Biogen
oral reversible BTK kinase inhibitor Ph. I candidate for multiple sclerosis from prior BTK inhibitor BIIB0685 Journal of Medicinal Chemistry Biogen